Reading time ( words)
Chemigraphic, the UK's leading Electronic Manufacturing Service provider, is proud to add the EN ISO 13485 Medical Devices standard to our list of accreditations. Intensive assessment by BSi has verified that our advanced systems and processes, many of which are unique to the UK market, provide the control and traceability demanded by the global life-critical Medical Equipment sector.
Commercial Director John Johnston comments: "Our Medical Technology customers recognize that Chemigraphic will continue to innovate with class-leading solutions and investment in optimal manufacturing process. For Medical OEMs yet to experience the benefits of Chemigraphic partnership, this accreditation provides assurance that we will effectively manage their product integration across the entire lifecycle, whatever their outsourcing strategy needs.
ISO 13485 now sits alongside ISO 9001, ISO 14001 and ISO 22301 (BCMS) accreditations and allows us to further promote our capability as the UK's premier Medical and High-Reliability Systems Integrator.
Share
Suggested Items
01/19/2023 |
Julia Gumminger, IPC
IPC APEX EXPO 2023 will offer a refreshed Professional Development Course program. This year’s conference includes something for everyone, including informative courses catering to technical managers ready to level up their careers. Thirty-six courses will be offered on Sunday, Jan. 22 and Monday, Jan. 23. Attendees will find both updated content from veteran instructors and innovative courses from new instructors.
12/19/2022 |
Gaurab Majumdar, IPC
For the first time, IPC APEX EXPO will host an “India Pavilion,” showcasing 16 Indian companies promoting India’s electronics manufacturing capabilities. The initiative was undertaken by the Ministry of Commerce & Industry, Government of India, and implemented by the Indian government agency, Electronics and Computer Software Export Promotion Council (ESC) India.
12/08/2022 |
Malcolm Thompson, NextFlex
As the global chip shortage continues, companies may be tempted to put research and development on the backburner to conserve capital and prioritize production. A primary area of focus has been on increasing production capabilities to meet demand. In this drive to increase capacity, R&D has fallen to the wayside as some companies consider scaling back to refocus on the expansion of manufacturing capacity at current technology nodes. This is a hard choice to make for any company, and even R&D giants like Apple, known for its dedicated investments in innovation, have had to cut R&D budgets below original projections.
